Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2022 15:21 ET | Source: Revibe Technologies

Revibe Technologies Announces Clinical Development Updates for its Investigational FokusRx Prescription Digital Therapy for the Treatment of ADHD

– FokusRx™ feasibility study demonstrates positive results – – Company plans to initiate Phase 3 trial with FokusRx in ADHD in the second half of 2022 – Wake Forest, North Carolina, Feb. 08,...